The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

Abstract Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. Methods Between August 2004 and November 2014, 104 patients with BCLC stage B/C HCC were enrolled at the Affili...

Full description

Bibliographic Details
Main Authors: Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Sorafenib
Transarterial chemoembolization
Portal vein tumor thrombus
Adverse events
Online Access:http://link.springer.com/article/10.1186/s12885-017-3545-5

Internet

http://link.springer.com/article/10.1186/s12885-017-3545-5

Similar Items